Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy ® for applications in early disease detection and precision ...

The dipeptidyl peptidase 1 (DPP-1) inhibitor cut the annualized rate of pulmonary exacerbations by around 20% compared with ...

aeruginosa infection can often receive adequate ... commercially available intravenous products. NA: Not available. Cystic fibrosis (CF) pulmonary disease is characterized by chronic and recurrent ...

inhaled multi-phage therapeutic for the treatment of chronic pulmonary Pseudomonas aeruginosa – P.a. or P. aeruginosa – infections in non-cystic fibrosis bronchiectasis, or NCFB, patients.

Cystic fibrosis (CF) is a multisystem ... will be well-informed partners in reducing acquisition of respiratory pathogens, particularly Pseudomonas aeruginosa and Burkholderia cepacia complex.

States screen for cystic fibrosis (CF) but with significant variation among their screening algorithms. The Cystic Fibrosis Foundation group conducted a systematic review, leading to seven ...

FRESNO, Calif. (KFSN) -- Cystic Fibrosis is a genetic disorder that affects the lungs, digestive system and other organs. Babies are screened for it when they are born. Now, those living with the ...

In a small study, CF patients treated with the therapy saw a reduction in multidrug-resistant lung bacteria and improved lung ...